INTRODUCTION
Inflammasomes are multimolecular complexes consisting of inactive pro-caspase-1 and members of the nucleotide-binding domain-leucine-rich repeat (NLR) family of immune system proteins (Latz, 2010) . The assembly of an inflammasome leads to proteolytic activation of caspase-1, which in turn cleaves pro-interleukin (IL)-1b and pro-IL-18 into mature forms (Latz, 2010) . Active IL-1b and IL-18 are essential members of host defenses toward various pathogens and may also participate in sterile inflammatory processes. The NLR family has more than 20 members; however, many of these proteins have unknown functions (Martinon et al., 2009) , and their relative roles in promoting resistance to infection are in many instances unclear. There is evidence supporting a function in bacterial recognition for several NLRs. These include NOD1/2 (recognizing peptidoglycan fragments) (Martinon et al., 2009 ), NLRP1 (sensing anthrax lethal toxin) (Averette et al., 2009 ), NLRP3 (activated by exposure to many pathogens, bacterial RNA, toxins, and crystal structures) Duewell et al., 2010; Halle et al., 2008; Hornung et al., 2008; Kanneganti et al., 2006; Sander et al., 2011) , NLRC4 (sensing of Salmonella, intracellular flagellin and bacterial type III secretion rod proteins) Miao et al., 2010) , and Naip5 (promoting resistance to Legionella) (Kofoed and Vance, 2011; Molofsky et al., 2006; Ren et al., 2006) . Recent results also suggested a role for NLRP6 in maintenance of bacterial homeostasis in the colon and for NLRP7 in the recognition of lipoproteins (Khare et al., 2012) . NLRP12 (also called Nalp12, Monarch-1, and Pypaf-7) was the first NLR shown in biochemical assays to interact with the adaptor protein Asc to form an active IL1b-maturing inflammasome . The role of NLRP12 in innate immunity has remained unclear. Both inflammatory and inhibitory functions have been suggested, as has a role in hypersensitivity (Allen et al., 2012; Arthur et al., 2010; Wang et al., 2002; Zaki et al., 2011) . Interestingly, like for NLRP3, mutations in NLRP12 are linked to hereditary inflammatory disease (Jé ru et al., 2008) , and mutations may lead to increased Asc speckle formation and caspase-1 activity (Jé ru et al., 2011b) . It has been reported that patients carrying NLRP12 mutations associated with increased inflammasome activation have been successfully treated with anti-IL-1 therapy, similar to patients containing mutations in NLRP3 (Hawkins et al., 2003; Jé ru et al., 2011a; Lachmann et al., 2009) . No previous studies have addressed the role of NLRP12 in host resistance to infectious agents.
Evading innate immunity early in infection plays a key role in virulence of many microorganisms including the plague bacillus Yersinia pestis (Cornelis, 2000; Perry and Fetherston, 1997; Stenseth et al., 2008) . This pathogen has several means of minimizing immune activation (Lathem et al., 2007; Monack et al., 1998; Mukherjee et al., 2006; Sodeinde et al., 1992; Zhou et al., 2005) , with the effect that bacterial replication can proceed with minimal interference by the immune system. As a result, plague is often characterized by very high bacterial numbers in patient sera and organs (Perry and Fetherston, 1997) . Major factors neutralizing host defenses by active means include a complex type III secretion system (T3SS) (Cornelis, 2002; Perry and Fetherston, 1997) , the plasminogen activator Pla (Lathem et al., 2007; Sodeinde et al., 1992) , and a high-affinity iron acquisition system (Perry and Fetherston, 1997) . The Yersinia T3SS delivers effector proteins, which disrupt signaling within the host cell to prevent phagocytosis, induce apoptosis, and evade the immune response (Cornelis, 2002) . Many Gram-negative bacteria, including Y. pseudotuberculosis, a very close ancestor of Y. pestis, produce a hexa-acylated lipid A and LPS, which has the potential of strongly triggering innate immunity via Toll-like receptor 4 (TLR4)-MD-2 signaling (Munford, 2008; Raetz et al., 2007; Rebeil et al., 2004; Therisod et al., 2002) . In contrast, Y. pestis generates a tetra-acylated lipid A-LPS that poorly induces TLR4-mediated cellular activation (Kawahara et al., 2002; Knirel et al., 2005; Montminy et al., 2006; Rebeil et al., 2006) . We have reported that expression of E. coli lpxL in Y. pestis, which lacks a homolog of this gene, forces the biosynthesis of a hexa-acylated LPS (Montminy et al., 2006) and that this single modification dramatically reduces virulence in wild-type mice, but not in mice lacking a functional TLR4. This emphasizes that avoiding activation of innate immunity is important for Y. pestis virulence. It also provides a model in which survival is strongly dependent on innate immune defenses, presenting a unique opportunity for evaluating relative importance of innate immunity signals in protection against bacterial infection.
One implication of TLR4 engagement is the induction of the immature forms of the central proinflammatory cytokines IL-1b and IL-18. TLR4 signaling can also promote expression of inflammasome components such as Nlrp3 (Bauernfeind et al., 2009) . This establishes links between TLR4 activation and the inflammasome pathways. In this study, we have used wildtype Y. pestis and attenuated strains expressing a strong TLR4-activating hexa-acylated LPS as a model system to investigate the involvement of NLRP12 in pathogen recognition and IL-18 -IL-1b release.
Here, we show that NLRP12 is an inflammasome component that is central in the recognition of Y. pestis and that IL-18 signaling substantially contributes to resistance against bacteria. Compared to wild-type mice, NLRP12-deficient animals had higher mortality and increased bacterial loads after infection, correlated with lower amounts of IL-18, IL-1b, and IFN-g. We propose a role for NLRP12 in the sensing of microbial pathogens. C has a tetra-acylated lipid A (Figure S1A available online) (Montminy et al., 2006) , whereas Y. pseudotuberculosis and Y. pestispYtbLpxL have a hexa-acylated lipid A ( Figure S1B ). Mice infected subcutaneously (s.c.) with 500 colony forming units (CFUs) of highly virulent Y. pestis KIM1001 rapidly succumb to infection ( Figure 1A ). All wild-type mice infected with KIM1001-pYtbLpxL expressing a hexa-acylated Y. pseudotuberculosislike lipid A survived ( Figure 1A) , and the animals were protected toward challenge with virulent KIM1001 (Table S1 ). Survival of mice was strongly TLR4 dependent ( Figure 1A ). To determine the pathways responsible for in vivo clearance, we infected mice from several strains deficient in inflammatory cytokines or cytokine receptors s.c. with 500 CFUs of KIM1001-pYtbLpxL ( Figure 1B) . Interestingly, 100% of the animals lacking IL-18 and IL-18R died, as did the TLR4-deficient mice and 70% of the IL-1R1-deficient mice. Weaker effects were observed in animals lacking IFN-abR, TNFR1, or IL-12p40 ( Figure 1B ). Resistance to infection in IL-1b-and IL-1R1-deficient animals was reduced to a similar degree, with $30% of animals surviving ( Figure 1C ). However, IL-18 was critically important for resistance to infection in this model, given that IL-18 and IL-18R-deficient mice developed symptoms of bubonic plague and rapidly succumbed to disease when infected with KIM1001-pYtbLpxL ( Figures 1B and 1D ). Because inflammasomes are responsible for processing of IL-18 and IL-1b into mature forms, this result indicates that this infection model is well-suited for the study of inflammasome mechanisms and implications of IL-18 release. Mice deficient in MyD88, an adaptor molecule common to TLR, IL-1R, and IL-18R signaling pathways, were more susceptible to wild-type Y. pestis KIM1001 than wild-type C57Bl/6 mice ( Figure S1C ) and are also highly susceptible to strains expressing lpxL (Montminy et al., 2006) . Intravenous (i.v.) infection causes systemic infection even when attenuated bacterial strains are used; hence the inflammatory capacity in tissues for various bacterial strains can better be compared with this route of delivery. We found elevated levels of spleen IL-1b and IL-18 after i.v. infection with Y. pestis and fully virulent KIM1001-induced lower cytokine levels as compared to KIM1001-pYtbLpxL producing the potent LPS ( Figures 1E and  1F) . A similar release pattern could also be seen in vitro with bone marrow-derived macrophages (BMDMs) ( Figure 1G ) after stimulation with KIM5 (a pgm mutant attenuated strain used for in vitro experiments) or KIM5-pYtbLpxL. Immunoblot analysis ( Figure 1H) 
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Immunity
The NLRP12 Inflammasome Recognizes Yersinia pestis (Agostini et al., 2004; Manji et al., 2002; Wang et al., 2002) , but little is known of the role of NLRP12 during infection. We infected both NLRP3-deficient and NLRP12-deficient mice (Figures 2A  and 2B ) s.c. with 500 CFUs of KIM1001-pYtbLpxL and found that only 20% of NLRP12-deficient mice survived the infection, whereas $50% of mice lacking NLRP3 survived. This suggests that NLRP12 plays an important role in host defense against some bacterial pathogens. In contrast, NLRP12-deficient mice were resistant to infection with Salmonella typhimurium, whereas TLR4-deficient mice all succumbed to the infectious challenge ( Figure 2C ). This indicates that NLRP12 deficient animals are not universally more sensitive to infections. The function of NLRP12 is not well understood, but mRNA is detectable in several organs and immune cells ( Figures S2A and S2B ), including macrophages, although prolonged macrophage maturation led to a decrease in expression ( Figure S2C ). NLRP12-deficient mice ( Figure S2D ) had a normal composition of cell populations in spleen and bone marrow ( Figure S2E ). Shown is representative of three to five performed experiments. *p < 0.05; **p < 0.01; ***p < 0.001. Also see Figure S1 and Table S1 .
The possible involvement of NLRP12 in maturation of IL-1b and IL-18 led us to perform in vitro experiments with mouse cells to study inflammasome components that promote caspase-1 cleavage and IL-1b-IL-18 release after infection with Y. pestis and modified strains. Neutrophils express more Nlrp12 than macrophages ( Figure S2B ), but the role of inflammasomes in pathogen-induced neutrophil release of IL-1b and IL-18 is not yet studied in detail for many microbes. We found that thioglycollate-elicited neutrophil-enriched peritoneal cells released IL-1b after Y. pestis infection ( Figure 3A ). When compared to cells from wild-type mice, the amounts of IL-1b, but not TNF (Figure S3A) released from the neutrophils lacking NLRP12, were markedly reduced after stimulation with Y. pestis strains. Moreover, infected neutrophils from the caspase-1-deficient mice lack IL-1b in the supernatant, suggesting that Y. pestis-induced neutrophil IL-1b release involves caspase-1 inflammasomes, although we cannot rule out a role for other neutrophil proteases (Netea et al., 2010) . It is also unclear which role caspase-11 plays relative to caspase-1 in Y. pestis-induced inflammasome activation, given that the caspase-1-deficient mice utilized in this study contain the same truncated and apparently nonfunctional caspase-11 as previously published (Kayagaki et al., 2011) . Macrophages deficient in NLRP12 or NLRP3 also had a reduced ability to release both IL-18 and IL-1b after infection with parental Y. pestis and Y. pestis-pYtbLpxL ( Figures 3B and 3C ). These observations are consistent with the survival data (Figure 2 ), which indicated that host recognition of Y. pestis involves NLRP12. Cells deficient in Asc and caspase-1 also had decreased IL-18 and IL-1b release ( Figures 3B and 3C) . Thus, NLRP12 signaling may occur parallel to or in cooperation with additional inflammasome components because NLRP12 deficiency did not completely block cytokine release. NLRP12 KO macrophages responded normally to alum, S. typhimurium ( Figure 3C ), nigericin, and poly(dA:dT) ( Figures S3B and S3C ), suggesting that NLRP12 may not participate in NLRP3, AIM2, or NLRC4 inflammasomes formed in response to those stimuli. None of the inflammasome proteins had an impact on TNF release ( Figure 3D ; Figure S3 ). Furthermore, NLRP12 deficiency had little impact on the expression of 31 selected macrophage genes, including Il1b, in the absence or presence of bacteria ( Figure S3C ). Many of those genes are controlled by NF-kB and/or MAP kinases. In a more detailed study, NF-kB signaling measured by IKK kinase assay and I-kB degradation was also largely preserved in NLRP12-deficient cells (Figures S3D and S3E) . Y. pestis pregrown at 26 C naturally expresses a hexaacylated LPS (Montminy et al., 2006) , and release of IL-1b in response to infection by 26 C grown bacteria was also influenced by NLRP12 ( Figure S3B ). Upon infection of wildtype and NLRP12 KO BMDMs with the human pathogens Y. pseudotuberculosis and Y. enterocolitica, ancestors of Y. pestis (Chain et al., 2004) , we observed a reduction in secreted IL-1b from the cells lacking NLRP12 (Figure 3E ), although TNF release was normal ( Figure S3F ). By using KIM6, a derivative of KIM5 that lacks the pCD1 virulence plasmid containing genes for the T3SS (Perry and Fetherston, 1997) , we found that the secretion system was necessary for stimulating IL-1b release, even in the presence of a highly stimulatory LPS as found in KIM6-pYtbLpxL ( Figure 3F ). YopJ may participate in inflammasome activation (Zheng et al., 2011) , and the deletion of YopJ or the T3SS translocon protein YopB reduced IL-1b release (Figure 3G) . Experiments performed using a strain with the expression of lpxL on a YopJ mutant background suggested that YopJ is a key player controlling IL-1b release, even in the presence of a stimulatory LPS ( Figure 3H ), although other T3SS-dependent factors may also regulate IL-1b (Brodsky et al., 2010) . The data suggest that the ligand(s) responsible for NLRP12 activation are dependent on the Yersinia T3SS. TLR4 plays a critical role in the IL-1b and IL-18 production after infection of the mouse macrophages ( Figure 3I ; Figure S3G ), although the relative importance of mouse versus human TLR4-MD-2 in inducing Y. pestis responses may differ. Rodent cells have higher ability to recognize hypoacylated lipid A (Lien et al., 2000; Montminy et al., 2006) . This might be influenced by a shallow positioning of the hypoacylated lipid A in mouse MD-2 compared to human MD-2, and the enabling of enhanced ionic interactions between hypoacylated lipid A and mouse TLR4, facilitating receptor cluster dimerization and signaling (Meng et al., 2010) . Our results indicate a role for both TLR4 and NLRP12 in the proinflammatory macrophage response against Y. pestis strains.
NLRP12 Is an Inflammasome Component
Upregulation of NLRP3 has been suggested to positively affect the activity of the NLRP3 inflammasome (Bauernfeind et al., 2009) . We therefore studied expression of Nlrp12 and Nlrp3 ( Figures 4A and 4B ) after infection of macrophages with KIM5 or KIM5-pYtbLpxL. Expression of Nlrp12 in BMDM was markedly increased after infection with Y. pestis strains and this may boost host responses to an infection. Treatment with LPS alone induced upregulation of Nlrp12 gene expression (Figure S4A) . Furthermore, Y. pestis-induced formation of cleaved and active caspase-1, as measured by an assay showing binding of active caspase-1 to a fluorescent substrate, was also impaired in NLRP12-deficient cells, providing evidence for NLRP12-dependent inflammasome function (Figures 4C and  4D ). Caspase-1 cleavage measured by this assay is also . Also see Figure S2 .
Immunity
The NLRP12 Inflammasome Recognizes Yersinia pestis decreased in spleen macrophages or neutrophils from NLRP12 KO mice 24 hr after infection with KIM1001 or KIM1001-pYtbLpxL ( Figures 4E and 4F ). Il1b gene expression was similar in infected wild-type cells and NLRP12 KO cells infected with Y. pestis ( Figure 4G ; Figure S3D ). The macrophages infected in vitro showed a reduction in caspase-1 and IL-1b processing by immunoblotting ( Figure 4H ), also cells infected at a higher m.o.i. (Figure S4B ). and NLRP12 KO BMDM (E); C57BL/6 BMDM (F and G); or C57BL/6 and TLR4 KO BMDMs (I). Infection with Yersinia strains occurred for 6 hr, with an addition of 50 mg/ml gentamicin to limit bacterial growth after 3 hr. Yersinia strains were added at 10 m.o.i., S. typhimurium at 1 m.o.i. Alum (130 mg/ml) stimulations (C and I) lasted 6 hr after priming for 3 hr with 10 ng/ml KIM5-YtbLpxL LPS. Shown are mean for triplicate cultures (with SD) in representative experiments out of three to ten performed. *p < 0.05; **p < 0.01; ***p < 0.001. Statistical comparisons are between wild-type cells and multiple mutant cells (A-E and I) or between unstimulated and multiple bacterial strains (F). Also see Figure S3 .
The NLRP12 Inflammasome Recognizes Yersinia pestis attenuated Y. pestis (KIM1001 or KIM1001-pYtbLpxL). At 44 hr after infection with KIM1001, IL-18 cytokine amounts were considerably lower in the NLRP12 KO mice, expressed as both cytokine normalized to the spleen bacterial load in each particular animal ( Figure 5A ) or simply as cytokine concentration in homogenate ( Figure S5A ). A decrease of IL-18 and IL-1b in the spleen ( Figures 5B and 5C ) and serum ( Figures 5D and 5E ) was also observed after KIM1001-pYtbLpxL infection in the (H) Immunoblot for caspase-1 p10 or IL-1b p17 in supernatant or cell lysate from BMDMs exposed for 10 hr to poly(dA:dT) (LPS primed as in Figure 3) , KIM5, or KIM5-pYtbLpxL. Shown is a representative of two (E-G) or three to five (A-D, H, and I) experiments. *p < 0.05; **p < 0.01; ***p < 0.001. Also see Figure S4 .
The NLRP12 Inflammasome Recognizes Yersinia pestis Figures 1B and 1D ). IL-18R KO mice had reduced IL-18 and IL-1b in the spleens compared to WT mice after infection with KIM1001-pYtbLpxL ( Figure S5B ), suggesting a positive feedback loop via IL-18R for IL-1b and IL-18 production. A reduction of several orders of magnitude in spleen bacterial load was seen when mice were infected i.v. with KIM1001-pYtbLpxL compared to wild-type KIM1001 ( Figure 5E ), indicating beneficial host responses induced by the presence of the hexa-acylated LPS. These differences in systemic bacterial load between the two bacterial strains were absent in mice lacking NLRP12 or IL-18R. NLRP12-deficient and IL-18R-deficient mice also had increased bacterial loads compared to wild-type mice when infected with the virulent Y. pestis KIM1001 (Figure 5E Figure 5F , left panels, marked with an asterisk) and remarkably few signs of inflammation, probably reflecting active suppression of immunity combined with stealth via limited initiation of TLR4 signaling. Livers from animals infected with Y. pestispYtbLpxL display foci consisting of inflammatory cells ( Figure 5F , upper right, indicated by arrows) and absence of visible bacterial masses, suggesting that recruitment of phagocytes limits bacterial growth (Montminy et al., 2006) . Livers from NLRP12 KO mice infected with KIM1001-pYtbLpxL had recruitment of inflammatory cells ( Figure 5F , arrows). Such masses of inflammatory cells typically contain large number of neutrophils and some mononuclear cells (Montminy et al., 2006) , and a calculation of number of recruited cells showed no significant difference between infected wild-type versus NLRP12-deficient livers ( Figure S5C ). However, this cell recruitment did not correlate with suppression of bacterial growth, given that bacterial masses were visible ( Figure 5F ). These results suggest that NLRP12 may not play a major role in the attraction of phagocytes to infected sites in the liver, but is central to the effective antibacterial actions they perform. Few if any inflammatory cells were visible in livers of IL-18R-deficient mice ( Figure 5F ), indicating failures of both cell recruitment and antibacterial defenses. Taken together, the results suggest that NLRP12 and IL-18 contribute to host resistance against Y. pestis and Y. pestispYtbLpxL. We also found that NLRP12 KO mice infected with KIM1001-pYtbLpxL had reduced amounts of TNF and the chemokine CXCL12 compared to C57Bl/6 mice ( Figures S5D-S5F ), possibly secondary effects of reduced IL-1b and IL-18 release, given that primary cells lacking NLRP12 did not display decreased TNF release in culture (Figure 2) . In contrast, NLRP12-deficient mice injected with an alum-LPS mixture did not show decreased serum IL-1b, IL-18, TNF-a, and CXCL12 ( Figure S5G ). Furthermore, we found similar recruitment of neutrophils to the peritoneum of wild-type mice or NLRP12-deficient mice injected intraperitoneally (i.p.) with sterile thioglycollate ( Figure S5H ). Movement of neutrophils ( Figure 5F ; Figure S5C ) and DCs ( Figure S5I ) during infection of NLRP12-deficient mice appears to be preserved. Differences in survival between NLRP12-deficient or IL-18-deficient mice and wildtype mice after s.c. infection with only 10 CFUs of fully virulent KIM1001 were not significant ( Figure 5G ). This result is of uncertain importance because the very low LD50 of Y. pestis by s.c. infection (less than 10 CFUs) makes it difficult to demonstrate reductions in host resistance impacting survival without the use of very large numbers of animals. Tissue bacterial loads ( Figure 5E ) appear to be more sensitive assays for analyzing host resistance to Y. pestis.
NLRP3 has also been proposed as an inflammasome component recognizing Y. pestis (Zheng et al., 2011) (Figures 2 and  3 ). NLRP3-deficient animals also were less resistant to infection by KIM1001-pYtbLpxL, in that they displayed increased bacterial loads in the spleen ( Figure 5H ) that correlated with reduced spleen cytokines ( Figure 5I ). In summation, NLRP12 and NLRP3 both contribute to the host resistance toward Y. pestis strains.
NLRP12 and IL-18 Signaling Induce IFN-g that Limits Infection
IL-18 is a known inducer of IFN-g (Okamura et al., 1995) , a key protein in many host responses to pathogens. This suggests that signaling via NLRP12 and the IL-18R, resulting in the release of IFN-g, could mediate resistance to Y. pestis-pYtbLpxL. Mice lacking both IFN-abR and IFN-gR (dKO) were infected with KIM1001-pYtbLpxL s.c., and we found that all the dKO animals succumbed to the infection ( Figure 6A ). This phenomenon was largely attributed to IFN-gR signaling, given that only a few mice lacking IFN-abR died upon infection, whereas almost all mice lacking IFN-gR succumbed ( Figure 6B ). No differences in IFN-g concentrations were observed between spleens of uninfected WT, NLRP12-deficient, and IL18R-deficient mice ( Figures  6C and 6D) . However, the IFN-g concentrations in spleens from KIM1001-pYtbLpxL-infected NLRP12-deficient mice compared to wild-type mice were drastically reduced ( Figure 6C ), as was also true for the mice lacking IL-18R ( Figure 6D ). Thus, we propose a cascade of signals from NLRP12 to IL-18 maturation that in turn mediates IFN-g release after infection with Y. pestis strains.
DISCUSSION
We propose that recognition of Y. pestis expressing a stimulatory LPS by TLR4 leads to upregulation of NLRP12 and proinflammatory cytokines such as IL-18 and IL-1b. NLRP12 then recognizes a ligand produced upon Y. pestis infection and assembles into an inflammasome that processes IL-18 and IL-1b. Although the precise nature of the true NLRP12 ligand is unknown, and it may be a host or bacterial protein, the generation of the ligand appears to require the virulence-associated T3SS of Yersinia. Models for activation may include possibilities that cells sense membrane damage associated with the T3SS, secreted effectors or other molecules channeled by the T3SS, and modified host proteins. NLRP3 also contributes to IL-18-IL-1b release. IL-18 seems to be more critical than IL-1b and plays a key role in induction of IFN-g.
We show that NLRP12 is an inflammasome component recognizing Y. pestis and contributes to in vivo resistance to infection with Y. pestis strains. To our knowledge, this is the first demonstration of a clear role for NLRP12 in resistance to infection. Our data suggest an inflammasome role for NLRP12 in pathogen recognition and that the NLRP12-IL-18-IFN-g axis is effective in limiting infection with Y. pestis-pYtbLpxL. We also show that the expression of Y. pseudotuberculosis LpxL in Y. pestis increases TLR4-dependent release of IL-18 and IL-1b. This increase correlates with increased resistance to the modified pathogen. In fact, the results indicate that a major consequence of producing LPS with low TLR4-activating potential could be lack of priming necessary for effective synthesis of active IL-1b and IL-18. Therefore, Y. pestis is able to utilize inflammasome-activating components like the T3SS to neutralize the immune response without an effective activation of an inflammatory response. This phenomenon may have played a role in evolution of high virulence in Y. pestis.
These findings support the view that inflammasomes, the cellular protein complexes cleaving IL-18 and IL-1b into mature forms, are fundamental components of the host response to many pathogens. Indeed, several viral, bacterial and fungal microbes have strongly increased ability to induce disease in the absence of IL-1b, IL-18 and inflammasome components (Broz et NLRP12 may also be involved in resisting infections caused by other human pathogens. It is unclear how NLRP12 may interact with other inflammasome components. NLRP12 deficiency did not cause a complete reduction in ability to release IL-18 and IL-1b after exposure to Y. pestis and Y. pestispYtbLpxL infection. Also, the increased mortality observed in NLRP12-deficient mice did not appear as great as observed in IL-18-deficient animals, and NLRP3 also plays a role in host defenses. Redundancy between NLRs may occur, and other NLRs may also participate in optimal responses to infection. This may support the idea that NLRs work together for optimal protection of the host (Broz et al., 2010) . The generation of animals with combined deficiencies in NLRP12 and other NLRs may clarify how NLRP12 functions in cooperation with other signaling components. NF-kB signaling after bacterial challenge appeared normal in NLRP12-deficient cells.
IL-18, IL-1b, and IFN-g are all cytokines active at the interface between innate and adaptive immunity. We have found that Y. pestis strains generating a hexa-acylated LPS could function as effective live vaccines (Montminy et al., 2006) . It would be of interest to investigate the role of NLRP12 in promoting the development of adaptive immunity and protection after vaccination with both live and subunit + adjuvant vaccines.
The emerging role of inflammasomes as key players in host defenses during many infections makes them desirable targets for therapeutic intervention and drug development. We note that alum, one of the first components known to activate specific inflammasomes, already is in widespread use as one of the few vaccine adjuvants licensed for human use. However, a delicate balance between pathological effects and enhanced host defenses arising from inflammasome-stimulating treatments will be necessary. Mutations in NLRs are linked to inflammatory diseases (Hawkins et al., 2003; Jé ru et al., 2011a) , and anti-IL-1 treatment does in fact reduce symptoms in many such patients. More knowledge on the role of NLRs in inflammation and homeostasis is needed in order to fine-tune future NLR-based therapies.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions Y. pestis KIM is originally a clinical isolate from a Kurdistan Iran man (Brubaker, 1970; Perry and Fetherston, 1997) . Y. pestis strains KIM5, KIM5-pEcLpxL (containing E. coli lpxL, earlier called pLpxL) and KIM1001 were as reported (Montminy et al., 2006 100 mg/ml of ampicillin. All strains containing plasmids above remained tetracycline sensitive. KIM1001 (pPCP1+, pCD1+, and pMT1+) is highly virulent (Perry and Fetherston, 1997) , whereas KIM5 bears the chromosomal deletion ''Dpgm,'' which substantially attenuates virulence. The pgm locus contains no genes thought to affect LPS biosynthesis. KIM6 is a KIM5 derivative lacking the T3SS-containing pCD1 virulence plasmid. KIM5-DYopB was provided by G. Plano (Torruellas et al., 2005) . For the generation of KIM5-DYopJ, the following method was used: An in-frame deletion removing codons 4-287 was created via allelic exchange. PCR products made with primer sets A (5
, respectfully, were used to make a fused product by overlap PCR using primers A and D (Horton et al., 1989) . This product was cloned in the allelic exchange vector pRE107 (Edwards et al., 1998) in E.coli K12 strain B2155 and transferred to Y. pestis by conjugation; recombinants were selected on TB medium containing 100 mg/ml ampicillin but no diaminopimelic acid. After counter selection with 5% sucrose, deletion mutants were identified by PCR. For in vitro infections, bacteria were grown overnight at 37 C in TB broth with or without ampicillin, diluted 1:4 in fresh media, and cultured for three more hours at 37 C, then washed three times with PBS and resuspended in DMEM or RPMI. S. enterica serovar typhimurium strain SL1344 was provided by M. O'Riordan and strain M525P by C. Bryant.
Cell Stimulations
Mouse BMDMs were prepared by maturing fresh bone marrow cells for 5-7 days in the presence of M-CSF containing supernatant from L929 cells. Mouse neutrophils were enriched by injecting 1 ml of thioglycolate i.p., peritoneal cells (typically >80% Ly6G-positive cells; Nilsen et al., 2004) were harvested 4 hr later after flushing with RPMI. Mouse BMDMs were plated at 2 3 10 5 per well in 96-well plates for ELISA or 2 3 10 6 per well in 12-well plates for immunoblotting.
Stimulation was for 6 hr and supernatants were collected for cytokine analysis. Three hours after bacterial infections, 50 mg/ml of gentamycin was added. Alum was from Pierce; nigericin and poly(dA:dT) was from Sigma. IL-1b p17 and Caspase-1 p10 immunoblots were conducted mainly as described )-deficient mice (Horai et al., 1998) were provided by Y. Iwakura. Wild-type (from Jackson Laboratories or bred at UMass) and knockout mice were infected s.c. in the nape of the neck with Y. pestis and their survival was monitored twice a day for 30 days. Mice were infected with 1000 CFUs of S. typhimurium M525P i.p. and survival was monitored as described above. For cytokine and CFU analysis, mice were infected either s.c. or i.v. and sacrificed at the indicated time points. Serum was generated by centrifugation in microtainer tubes (BD), and spleens were homogenized in 0.5 ml PBS with a closed system Miltenyi gentleMACS dissociator and c-tubes to preserve intact cells; subsequently cells/debris were removed by centrifugation. Samples for cytokine analysis were subjected to protease inhibitor (Roche) treatment. Cytokine amounts normalized by bacterial loads were calculated by dividing IL-18 concentrations (ng/ml) by the bacterial load (CFUs 3 10 8 )
for each animal. Hematoxylin and eosin (H&E) staining and microscopy were performed as published (Montminy et al., 2006) . In Vivo Caspase-1 Cleavage Analysis Mice were infected with 500 CFUs of Y. pestis i.p. After 24 hr, spleens were harvested and homogenized and cell suspensions were stained with caspase-1 FLICA reagent.
Statistical Analysis
In vitro cytokine release was analyzed by two-way ANOVA with a Bonferroni post-test. Differences in spleen and serum cytokine concentrations were analyzed by the unpaired t test. Differences in survival were studied with Kaplan-Meyer analysis and the logrank test. Differences in spleen CFUs or cytokine/CFU ratio values between genotypes of mice were evaluated with the Mann-Whitney test or in more complex comparisons involving multiple mouse genotypes, with a generalized linear regression model of cubic transformed log CFU values (95% confidence interval), to meet normality assumptions. Values of p < 0.05 were considered significant. 
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